Analytical Data
-
Gene name
mas5
- Application
-
Alternative Names
mas5; SPBC1734.11; Mitochondrial protein import protein mas5
-
Species
SchizosaccharoMyces pombe
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O74752
-
Expression Region
1-404aa
-
Molecular Weight
51.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MAS5 (Myrmecophilous Antigen 5) is a recombinant protein that has garnered significant attention in the field of molecular biology and immunology due to its potential applications in vaccine development and disease diagnostics. Originally identified in specific ant species, MAS5 is characterized by its unique antigenic properties that elicit strong immune responses. Researchers are particularly interested in MAS5 for its ability to induce both humoral and cell-mediated immunity, making it a promising candidate for use in immunotherapeutic strategies against various pathogens. With the increasing incidence of emerging infectious diseases and the need for effective vaccines, MAS5 provides a novel avenue for exploration. Key studies have focused on the structural analysis of MAS5, its interactions with immune cells, and the optimization of recombinant expression systems to produce MAS5 in sufficient quantities for further research. Additionally, ongoing investigations aim to understand the protein's mechanisms of action and its potential role in modulating immune responses. As researchers continue to explore the versatility of MAS5, it holds promise not only for vaccine formulation but also for therapeutic applications that enhance immune responses, paving the way for innovative treatments in the face of global health challenges.
